These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20008287)

  • 1. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.
    Asano J; Tada H; Onai N; Sato T; Horie Y; Fujimoto Y; Fukase K; Suzuki A; Mak TW; Ohteki T
    J Immunol; 2010 Jan; 184(2):736-45. PubMed ID: 20008287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
    Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
    J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
    Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
    Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation.
    Keller SA; Schwarz K; Manolova V; von Allmen CE; Kinzler MG; Bauer M; Muntwiler S; Saudan P; Bachmann MF
    Eur J Immunol; 2010 Jan; 40(1):103-12. PubMed ID: 19877013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
    Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
    Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
    Tan XH; Liu C; Wan YH
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor.
    McDonnell AM; Prosser AC; van Bruggen I; Robinson BW; Currie AJ
    Eur J Immunol; 2010 Jun; 40(6):1617-27. PubMed ID: 20373290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
    Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
    Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner.
    Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK
    Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
    Backer R; van Leeuwen F; Kraal G; den Haan JM
    Eur J Immunol; 2008 Feb; 38(2):370-80. PubMed ID: 18200498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.